文献速递功能神经外科

苍白球内侧部与丘脑底核脑深部电刺激治疗Meige综合征的短期与长期疗效比较:回顾性研究

Globus pallidus internus versus subthalamic nucleus deep brain stimulation for Meige syndrome: a retrospective study on short- and long-term efficacy.
PubMed 文献 · J Neurosurg · 2026-02-06

本研究回顾性分析2018年10月至2024年10月单中心162例原发性Meige综合征患者,其中83例接受GPi-DBS、79例接受STN-DBS。主要结局为BFMDRS-M评分变化,术后3个月及平均37.2个月随访时两组改善率相近,短期(p=0.602)与长期(p=0.419)疗效均无显著差异。

要点

  • GPi-DBS与STN-DBS对Meige综合征短期及长期疗效均有效且无显著差异。
  • 术后3个月BFMDRS-M平均改善率GPi组53.3%、STN组53.6%。
  • 末次随访平均37.2个月改善率GPi组63.0%、STN组65.2%。

核心结论

  • GPi-DBS与STN-DBS治疗Meige综合征均有效,总体疗效无显著差异,仍需进一步研究证实。

研究设计与样本

  • 单中心回顾性研究,分析2018年10月至2024年10月接受GPi-DBS或STN-DBS的原发性Meige综合征患者。
  • 共纳入162例患者(110例女性,平均年龄57.8岁),其中83例接受GPi-DBS、79例接受STN-DBS。
  • 主要结局指标为Burke-Fahn-Marsden肌张力障碍评定量表运动部分(BFMDRS-M)评分,于术前、术后3个月及平均37.2个月随访时评估。

主要发现

  • GPi-DBS组术后3个月BFMDRS-M平均改善率为53.3%,末次随访为63.0%。
  • STN-DBS组术后3个月平均改善率为53.6%,末次随访为65.2%。
  • 末次随访时GPi-DBS组71.1%、STN-DBS组70.9%的患者改善≥50%;分别有41.0%和46.8%的患者改善>75%。
  • 两组短期疗效(p=0.602)与长期疗效(p=0.419)均无显著差异。

临床怎么用

  • 对于药物和肉毒毒素治疗效果不佳的原发性Meige综合征,GPi-DBS与STN-DBS均可作为有效选择。
  • 靶点选择可综合考虑患者具体情况,两者短期与长期疗效相似。

局限性

  • 本研究为单中心回顾性研究,结论需进一步研究确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Meige syndrome is a complex movement disorder characterized by blepharospasm and oromandibular dystonia that is often resistant to conventional pharmacological and botulinum toxin treatments. Deep brain stimulation (DBS) offers a promising alternative, but the relative efficacy of globus pallidus internus (GPi) versus subthalamic nucleus (STN) targeting remains underexplored. Therefore, the aim of this study was to evaluate and compare the short- and long-term efficacy of GPi-DBS and STN-DBS in managing Meige syndrome. METHODS: This retrospective study analyzed patients with primary Meige syndrome who underwent either GPi-DBS or STN-DBS at a single institution from October 2018 to October 2024. The main outcome measure was the change in the Burke-Fahn-Marsden Dystonia Rating Scale for movement (BFMDRS-M) scores, which were assessed preoperatively and at 3 months and a mean of 37.2 months postoperatively. RESULTS: Of 162 patients (110 female, mean age 57.8 years) included in the analysis, 83 underwent GPi-DBS and 79 underwent STN-DBS. The GPi-DBS group had an average improvement rate of 53.3% in the mean BFMDRS-M score at 3 months postoperatively and 63.0% at the final follow-up. Similarly, the STN-DBS group had average improvement rates of 53.6% at 3 months and 65.2% at the final follow-up. At the final follow-up, 71.1% of patients in the GPi-DBS group and 70.9% of patients in the STN-DBS group had ≥ 50% improvement, while 41.0% and 46.8%, respectively, had > 75% improvement. There was no significant difference in short-term (p = 0.602) or long-term (p = 0.419) efficacy between the two groups. CONCLUSIONS: GPi-DBS and STN-DBS are both effective for the management of Meige syndrome, with no significant difference in overall efficacy. However, further research is required to confirm these findings.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Wu G, Weng JC, Liu M, et al. Globus pallidus internus versus subthalamic nucleus deep brain stimulation for Meige syndrome: a retrospective study on short- and long-term efficacy. J Neurosurg. 2026. PMID: 41650451. doi:10.3171/2025.9.JNS251420

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。